Latest filingAug 31, 2026Most recent Form 4
TRDA
Entrada Therapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$215M12 sells
Net open-market-$215M13 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period12transactions
- S · Open-market sells · dominant12 · 100%
Activity by reported role
A joint filing can contribute to multiple roles12transactions
- 10% owner · dominant12 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (13)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeMpm Bioventures 2018, L.P.Common Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
MPM BioVentures 2018 GP LLCCommon Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
MPM BioVentures 2018 LLCCommon Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
Gadicke AnsbertCommon Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
Evnin LukeCommon Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
Foley ToddCommon Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
MPM BioVentures 2014, L.P.Common Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
MPM BioVentures 2014 (B), L.P.Common Stock · Indirect · See Footnote
4,231,434Aug 31, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
TRDA transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
Entrada Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Entrada Therapeutics, Inc.?
MPM BioVentures 2018 GP LLC, MPM BioVentures 2018 LLC, MPM BIOVENTURES 2018, L.P., EVNIN LUKE, Foley Todd, GADICKE ANSBERT, MPM Asset Management Investors BV2014 LLC, MPM ASSET MANAGEMENT INVESTORS BV2018 LLC, MPM BioVentures 2014 (B), L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, MPM BioVentures 2014, L.P..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Mpm Bioventures 2018, L.P. reported a sale on Aug 31, 2026 valued at $30.9M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $2,154,645.96. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.